$FZMD
Fuse Medical, Inc.

2016 Form 10-K Financial Statement

#000156459017004799 Filed on March 20, 2017

View on sec.gov

Income Statement

Concept 2016 2015 Q4 2015
Revenue $567.6K $480.0K $1.677M
YoY Change -66.15% 54.84% 78.16%
Cost Of Revenue $204.0K $230.0K $664.3K
YoY Change -69.28% -8.0% 36.85%
Gross Profit $363.6K $260.0K $1.012M
YoY Change -64.09% 333.33% 122.15%
Gross Profit Margin 64.05% 54.17% 60.38%
Selling, General & Admin $4.171M $240.0K $1.804M
YoY Change 131.15% -40.0% 22.76%
% of Gross Profit 1147.21% 92.31% 178.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $19.09K $10.00K $25.07K
YoY Change -23.86% 88.8%
% of Gross Profit 5.25% 3.85% 2.48%
Operating Expenses $11.25M $240.0K $1.807M
YoY Change 522.45% -40.0% 22.92%
Operating Profit $3.163M $20.00K -$794.4K
YoY Change -498.2% -105.88% -21.67%
Interest Expense $146.9K $0.00 $6.712K
YoY Change 2088.93% -100.0% -109.53%
% of Operating Profit 4.64% 0.0%
Other Income/Expense, Net -$146.9K -$7.112K
YoY Change 1965.82%
Pretax Income $3.016M $10.00K -$801.6K
YoY Change -476.33% -102.86% -42.95%
Income Tax $51.63K $0.00 $0.00
% Of Pretax Income 1.71% 0.0%
Net Earnings $3.016M $10.00K -$801.5K
YoY Change -476.33% -102.86% -42.95%
Net Earnings / Revenue 531.44% 2.08% -47.81%
Basic Earnings Per Share $0.42
Diluted Earnings Per Share $0.33 $1.449K -$129.5K
COMMON SHARES
Basic Shares Outstanding 7.186M
Diluted Shares Outstanding 9.215M

Balance Sheet

Concept 2016 2015 Q4 2015
SHORT-TERM ASSETS
Cash & Short-Term Investments $778.5K $10.00K $8.160K
YoY Change 9439.83% -85.71% -87.92%
Cash & Equivalents $778.5K $8.157K $8.160K
Short-Term Investments
Other Short-Term Assets $23.02K $20.00K $18.83K
YoY Change 22.25% -60.0% -61.77%
Inventory $11.43M $81.21K $81.21K
Prepaid Expenses
Receivables $6.508M $298.0K $298.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $18.74M $406.2K $406.2K
YoY Change 4512.54% -17.1% -17.84%
LONG-TERM ASSETS
Property, Plant & Equipment $14.75K $24.98K $24.98K
YoY Change -40.95% -50.04% -48.98%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.820K $0.00 $3.820K
YoY Change 0.0%
Other Assets
YoY Change
Total Long-Term Assets $839.2K $28.80K $28.80K
YoY Change 2813.96% -52.0% -44.02%
TOTAL ASSETS
Total Short-Term Assets $18.74M $406.2K $406.2K
Total Long-Term Assets $839.2K $28.80K $28.80K
Total Assets $19.58M $435.0K $435.0K
YoY Change 4400.08% -20.91% -20.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.453M $247.2K $317.8K
YoY Change 671.89% -22.76% -0.62%
Accrued Expenses $3.068M $12.27K $12.27K
YoY Change 24904.48% 22.67% 18.32%
Deferred Revenue
YoY Change
Short-Term Debt $3.455M $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.976M $330.0K $330.1K
YoY Change 2619.68% -5.7% -4.99%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $100.0K $100.0K
YoY Change -100.0%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $0.00 $100.0K $100.0K
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.976M $330.0K $330.1K
Total Long-Term Liabilities $0.00 $100.0K $100.0K
Total Liabilities $8.976M $430.0K $430.1K
YoY Change 1987.27% 22.87% 23.8%
SHAREHOLDERS EQUITY
Retained Earnings -$2.315M
YoY Change
Common Stock $2.320M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.60M $7.998M $4.960K
YoY Change
Total Liabilities & Shareholders Equity $19.58M $435.0K $435.0K
YoY Change 4400.08% -20.91% -20.31%

Cashflow Statement

Concept 2016 2015 Q4 2015
OPERATING ACTIVITIES
Net Income $3.016M $10.00K -$801.5K
YoY Change -476.33% -102.86% -42.95%
Depreciation, Depletion And Amortization $19.09K $10.00K $25.07K
YoY Change -23.86% 88.8%
Cash From Operating Activities $2.790M -$50.00K -$375.1K
YoY Change -843.81% -83.87% -67.9%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$10.00K $8.308K
YoY Change -100.0% -113.63%
Acquisitions
YoY Change
Other Investing Activities $655.4K $0.00 $1.300K
YoY Change 50314.62% -113.89%
Cash From Investing Activities $655.4K -$10.00K -$7.010K
YoY Change -9449.36% -90.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.931M 0.000 322.8K
YoY Change -1008.11% -100.0% -75.06%
NET CHANGE
Cash From Operating Activities 2.790M -50.00K -375.1K
Cash From Investing Activities 655.4K -10.00K -7.010K
Cash From Financing Activities -2.931M 0.000 322.8K
Net Change In Cash 514.8K -60.00K -59.40K
YoY Change -966.7% -86.96% -207.57%
FREE CASH FLOW
Cash From Operating Activities $2.790M -$50.00K -$375.1K
Capital Expenditures $0.00 -$10.00K $8.308K
Free Cash Flow $2.790M -$40.00K -$383.4K
YoY Change -827.7% -87.1% -65.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-59398
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12267
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8157
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
298011
CY2015Q4 us-gaap Inventory Net
InventoryNet
81209
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
18828
CY2015Q4 us-gaap Assets Current
AssetsCurrent
406205
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24978
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
4957
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
247179
CY2015Q4 us-gaap Assets
Assets
435005
CY2016 dei Entity Registrant Name
EntityRegistrantName
Fuse Medical, Inc.
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0000319016
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2016Q2 dei Entity Public Float
EntityPublicFloat
147604
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2015Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
3822
CY2015Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
70602
CY2016Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
150000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
316532
CY2015Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
100000
CY2016Q4 us-gaap Liabilities
Liabilities
316532
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
158908
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3192686
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2900979
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
450615
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
767147
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6890808
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6890808
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
567607
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
1676609
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
204044
CY2016 us-gaap Gross Profit
GrossProfit
363563
CY2015 us-gaap Gross Profit
GrossProfit
1012343
CY2016 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
854050
CY2015 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
1804371
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-1580
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2407
CY2016 us-gaap Operating Expenses
OperatingExpenses
855630
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
308026
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2315044
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
68908
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2251093
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
330048
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
664266
CY2015Q4 us-gaap Liabilities
Liabilities
430048
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
435005
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
15890808
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15890808
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34198
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
15145
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2016Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
421636
CY2015 us-gaap Operating Expenses
OperatingExpenses
1806778
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-492067
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-794435
CY2016 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-129385
CY2015 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-7112
CY2016 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
35517
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-93868
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7112
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-585935
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-801547
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.13
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7185890
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
6189329
CY2016 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
103578
CY2015 us-gaap Related Parties Amount In Cost Of Sales
RelatedPartiesAmountInCostOfSales
431102
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
198504
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
190000
CY2015 fzmd Fair Value Of Vested Stock Options
FairValueOfVestedStockOptions
168000
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
250000
CY2016 fzmd Recognition Of Beneficial Conversion Feature On Convertible Promissory Notes Issued
RecognitionOfBeneficialConversionFeatureOnConvertiblePromissoryNotesIssued
117500
CY2016 fzmd Fair Value Of Vested Stock Options
FairValueOfVestedStockOptions
63000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
655391
CY2016 fzmd Contribution Of Capital By Stockholders
ContributionOfCapitalByStockholders
91533
CY2016 fzmd Debt Instrument Related Parties Forgiveness Accrued And Unpaid Interest
DebtInstrumentRelatedPartiesForgivenessAccruedAndUnpaidInterest
104169
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
117500
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
63000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
418000
CY2016 us-gaap Depreciation
Depreciation
14167
CY2015 us-gaap Depreciation
Depreciation
25073
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
15145
CY2015 fzmd Settlement Of Expense Reimbursement
SettlementOfExpenseReimbursement
6000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-239946
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
116920
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-55883
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-50173
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-15300
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-30422
CY2015 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
-3822
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-128252
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15897
CY2016 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
6576
CY2015 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-17869
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3002
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1901
CY2016 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
-848
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-237906
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-375140
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8308
CY2016 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
300
CY2015 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1300
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
300
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-7008
CY2016 fzmd Proceeds From Issuance Of Promissory Notes To Related Parties
ProceedsFromIssuanceOfPromissoryNotesToRelatedParties
150000
CY2015 fzmd Proceeds From Issuance Of Promissory Notes To Related Parties
ProceedsFromIssuanceOfPromissoryNotesToRelatedParties
100000
CY2016 fzmd Proceeds From Issuance Of Common Stock Net Of Offering Costs
ProceedsFromIssuanceOfCommonStockNetOfOfferingCosts
655391
CY2015 fzmd Proceeds From Issuance Of Common Stock Net Of Offering Costs
ProceedsFromIssuanceOfCommonStockNetOfOfferingCosts
190000
CY2016 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
91533
CY2015 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
43240
CY2015 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
93240
CY2015 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
17250
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
896924
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
322750
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
659318
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67555
CY2016 us-gaap Interest Paid
InterestPaid
6416
CY2015 us-gaap Interest Paid
InterestPaid
3337
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35014
CY2016 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
117500
CY2016 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
104169
CY2015 fzmd Transfer Security Deposit As Part Of Expense Reimbursement
TransferSecurityDepositAsPartOfExpenseReimbursement
2489
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts in the consolidated financial statements.&nbsp;&nbsp;Actual results could differ from those estimates.&nbsp;&nbsp;Significant estimates in the accompanying consolidated financial statements include the allowance for doubtful accounts, valuation of inventories, the estimates of depreciable lives and valuation of property and equipment, and the valuation allowance on deferred tax assets.</p></div>
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain amounts in the accompanying 2015 financial statements have been reclassified in order to conform to the 2016 presentation.</p></div>
CY2016Q4 us-gaap Cash
Cash
667475
CY2016Q4 fzmd Working Capital
WorkingCapital
437862
fzmd Proceeds From Issuance Of Promissory Notes To Related Parties
ProceedsFromIssuanceOfPromissoryNotesToRelatedParties
150000
CY2016 fzmd Options To Purchase Included In Common Stock Equivalents
OptionsToPurchaseIncludedInCommonStockEquivalents
1304788
CY2015 fzmd Options To Purchase Included In Common Stock Equivalents
OptionsToPurchaseIncludedInCommonStockEquivalents
609576
CY2015Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2016Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2015Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2016Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
0
CY2016Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
0
CY2016 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43945
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
59176
CY2015Q3 fzmd Transfer Security Deposit As Part Of Expense Reimbursement
TransferSecurityDepositAsPartOfExpenseReimbursement
2489
CY2015Q3 fzmd Transfer Of Property And Equipment Net Of Book Value As Part Of Expense Reimbursement
TransferOfPropertyAndEquipmentNetOfBookValueAsPartOfExpenseReimbursement
3062
CY2015Q3 fzmd Settlement Of Expense Reimbursement
SettlementOfExpenseReimbursement
6000
CY2015Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
449
CY2016Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
150000
CY2015Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
100000
CY2016 us-gaap Interest Expense
InterestExpense
129385
CY2015 us-gaap Interest Expense
InterestExpense
6712
CY2016 us-gaap Loss Contingency Lawsuit Filing Date
LossContingencyLawsuitFilingDate
January 27, 2014
CY2016 us-gaap Loss Contingency Name Of Plaintiff
LossContingencyNameOfPlaintiff
M. Richard Cutler and Cutler Law Group, P.C.
CY2016 us-gaap Loss Contingency Name Of Defendant
LossContingencyNameOfDefendant
Fuse, Alan Meeker, Rusty Shelton, Jonathan Brown, Robert H. Donehew and Golf Rounds.com, Inc.
CY2016 us-gaap Loss Contingency Date Of Dismissal
LossContingencyDateOfDismissal
2014-04-21
CY2016 us-gaap Loss Contingency Actions Taken By Plaintiff
LossContingencyActionsTakenByPlaintiff
On April 21, 2014, the complaint was dismissed for “want of prosecution.” The Plaintiffs had 30 days from April 21, 2014 to file a motion to reinstate the case and no timely action was taken by the Plaintiffs. However, the Plaintiffs did file a motion to reinstate on May 22, 2014 and it was granted.
CY2016 us-gaap Legal Fees
LegalFees
4343
CY2016 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
46465
CY2016 fzmd Sub Lease Rental Arrangements Lease Term Extension Option Maximum
SubLeaseRentalArrangementsLeaseTermExtensionOptionMaximum
2020-09-30
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
53465
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
33791
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
47124
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
35910
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
83034
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y6M
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y2M12D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.62
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.23
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.62
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
2.23
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0143
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0105
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
609576
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
700000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
4788
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1304788
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1204788
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.42
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.11
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
8.77
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.22
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.22
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y3M18D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M18D
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
35000
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
35000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.09
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.28
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
224381
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
623287
CY2015Q4 fzmd Deferred Tax Assets Accounts Receivable
DeferredTaxAssetsAccountsReceivable
5301
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
80850
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
58800
CY2015Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
12594
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
305231
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
699982
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2795
CY2015Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
731
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
2795
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
731
CY2016Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
308026
CY2015Q4 fzmd Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
700713
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
700713
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
432730
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-392687
CY2015 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
267983
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
641088
CY2016 fzmd Net Operating Loss Carryforwards Earliest Expiration Year
NetOperatingLossCarryforwardsEarliestExpirationYear
2017
CY2016 fzmd Net Operating Loss Carryforwards Latest Expiration Year
NetOperatingLossCarryforwardsLatestExpirationYear
2036
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2016 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.002
CY2015 fzmd Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.005
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-1.018
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.012
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.670
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.333
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2016Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0
CY2015Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0

Files In Submission

Name View Source Status
0001564590-17-004799-index-headers.html Edgar Link pending
0001564590-17-004799-index.html Edgar Link pending
0001564590-17-004799.txt Edgar Link pending
0001564590-17-004799-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
fzmd-10k_20161231.htm Edgar Link pending
fzmd-20161231.xml Edgar Link completed
fzmd-20161231.xsd Edgar Link pending
fzmd-20161231_cal.xml Edgar Link unprocessable
fzmd-20161231_def.xml Edgar Link unprocessable
fzmd-20161231_lab.xml Edgar Link unprocessable
fzmd-20161231_pre.xml Edgar Link unprocessable
fzmd-ex1031_324.htm Edgar Link pending
fzmd-ex1032_325.htm Edgar Link pending
fzmd-ex1033_322.htm Edgar Link pending
fzmd-ex1050_323.htm Edgar Link pending
fzmd-ex311_288.htm Edgar Link pending
fzmd-ex312_286.htm Edgar Link pending
fzmd-ex321_287.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending